MaxCyte, Inc.MXCTNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-136.22%
↓ 96% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
-69.37%
Historical baseline
PeriodValueYoY Change
TTM-136.22%-13.4%
2024-120.14%-12.4%
2023-106.88%-91.8%
2022-55.72%-13.7%
2021-49.02%-29.0%
2020-38.00%+29.2%
2019-53.65%-13.0%
2018-47.46%+27.4%
2017-65.42%-208.5%
2016-21.21%-